Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids
Launched by UNIVERSITY OF NEBRASKA · Mar 14, 2025
Trial Information
Current as of April 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effects of butyric acid, a substance that may help improve gut health, in young children who have congenital heart disease (CHD) and will be undergoing heart surgery. Researchers want to see if giving butyric acid before surgery is safe and if it can help reduce inflammation and improve gut function in these children. The trial will include infants and children aged 1 month to 3 years who will have surgery that requires a special machine called a cardiopulmonary bypass, which helps the heart and lungs work while the surgery is happening.
To participate, children must be scheduled for cardiac surgery and not have had antibiotics, surgery, or chemotherapy in the eight weeks before the study. They also should not be receiving certain types of feeding or have specific digestive system issues. During the trial, participants will receive butyric acid and be monitored for any side effects, as well as changes in their gut health. This study is important because it could provide new insights into how to support the health of young children with CHD during their recovery from surgery. The trial is not yet recruiting participants, but it aims to help improve care for these patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants and Children undergoing cardiac surgery with cardiopulmonary bypass
- Exclusion Criteria:
- • Antibiotics, surgery, or chemotherapy within the past 8 weeks
- • Continuous enteral feeds before surgery
- • GI pathology or intestinal surgery (excluding G-tube)
- • Liver disease with elevated transaminitis or dialysis-dependent renal disease
About University Of Nebraska
The University of Nebraska is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong commitment to improving patient outcomes and fostering scientific discovery, the university collaborates with various healthcare professionals and researchers to conduct rigorous clinical studies across diverse medical fields. The institution prioritizes ethical standards and patient safety while striving to translate research findings into practical solutions that enhance medical practices and contribute to the overall well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Omaha, Nebraska, United States
Patients applied
Trial Officials
Jeffrey Salomon, MD, MBA
Principal Investigator
University of Nebraska
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported